Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies

Alternative splicing is an essential regulatory mechanism for gene expression in mammalian cells contributing to protein, cellular, and species diversity. In cancer, alternative splicing is frequently disturbed, leading to changes in the expression of alternatively spliced protein isoforms. Advances...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tülay Karakulak, Holger Moch, Christian von Mering, Abdullah Kahraman
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/b81a7f5d0cbe4d7aadd5452cb9527017
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b81a7f5d0cbe4d7aadd5452cb9527017
record_format dspace
spelling oai:doaj.org-article:b81a7f5d0cbe4d7aadd5452cb95270172021-11-30T13:38:58ZProbing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies2296-889X10.3389/fmolb.2021.726902https://doaj.org/article/b81a7f5d0cbe4d7aadd5452cb95270172021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmolb.2021.726902/fullhttps://doaj.org/toc/2296-889XAlternative splicing is an essential regulatory mechanism for gene expression in mammalian cells contributing to protein, cellular, and species diversity. In cancer, alternative splicing is frequently disturbed, leading to changes in the expression of alternatively spliced protein isoforms. Advances in sequencing technologies and analysis methods led to new insights into the extent and functional impact of disturbed alternative splicing events. In this review, we give a brief overview of the molecular mechanisms driving alternative splicing, highlight the function of alternative splicing in healthy tissues and describe how alternative splicing is disrupted in cancer. We summarize current available computational tools for analyzing differential transcript usage, isoform switching events, and the pathogenic impact of cancer-specific splicing events. Finally, the strategies of three recent pan-cancer studies on isoform switching events are compared. Their methodological similarities and discrepancies are highlighted and lessons learned from the comparison are listed. We hope that our assessment will lead to new and more robust methods for cancer-specific transcript detection and help to produce more accurate functional impact predictions of isoform switching events.Tülay KarakulakTülay KarakulakTülay KarakulakHolger MochHolger MochChristian von MeringChristian von MeringAbdullah KahramanAbdullah KahramanFrontiers Media S.A.articlealternative splicingisoform switchingpan-cancer analysisbioinformatics tools and databasesdifferential transcript usageBiology (General)QH301-705.5ENFrontiers in Molecular Biosciences, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic alternative splicing
isoform switching
pan-cancer analysis
bioinformatics tools and databases
differential transcript usage
Biology (General)
QH301-705.5
spellingShingle alternative splicing
isoform switching
pan-cancer analysis
bioinformatics tools and databases
differential transcript usage
Biology (General)
QH301-705.5
Tülay Karakulak
Tülay Karakulak
Tülay Karakulak
Holger Moch
Holger Moch
Christian von Mering
Christian von Mering
Abdullah Kahraman
Abdullah Kahraman
Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies
description Alternative splicing is an essential regulatory mechanism for gene expression in mammalian cells contributing to protein, cellular, and species diversity. In cancer, alternative splicing is frequently disturbed, leading to changes in the expression of alternatively spliced protein isoforms. Advances in sequencing technologies and analysis methods led to new insights into the extent and functional impact of disturbed alternative splicing events. In this review, we give a brief overview of the molecular mechanisms driving alternative splicing, highlight the function of alternative splicing in healthy tissues and describe how alternative splicing is disrupted in cancer. We summarize current available computational tools for analyzing differential transcript usage, isoform switching events, and the pathogenic impact of cancer-specific splicing events. Finally, the strategies of three recent pan-cancer studies on isoform switching events are compared. Their methodological similarities and discrepancies are highlighted and lessons learned from the comparison are listed. We hope that our assessment will lead to new and more robust methods for cancer-specific transcript detection and help to produce more accurate functional impact predictions of isoform switching events.
format article
author Tülay Karakulak
Tülay Karakulak
Tülay Karakulak
Holger Moch
Holger Moch
Christian von Mering
Christian von Mering
Abdullah Kahraman
Abdullah Kahraman
author_facet Tülay Karakulak
Tülay Karakulak
Tülay Karakulak
Holger Moch
Holger Moch
Christian von Mering
Christian von Mering
Abdullah Kahraman
Abdullah Kahraman
author_sort Tülay Karakulak
title Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies
title_short Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies
title_full Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies
title_fullStr Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies
title_full_unstemmed Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies
title_sort probing isoform switching events in various cancer types: lessons from pan-cancer studies
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/b81a7f5d0cbe4d7aadd5452cb9527017
work_keys_str_mv AT tulaykarakulak probingisoformswitchingeventsinvariouscancertypeslessonsfrompancancerstudies
AT tulaykarakulak probingisoformswitchingeventsinvariouscancertypeslessonsfrompancancerstudies
AT tulaykarakulak probingisoformswitchingeventsinvariouscancertypeslessonsfrompancancerstudies
AT holgermoch probingisoformswitchingeventsinvariouscancertypeslessonsfrompancancerstudies
AT holgermoch probingisoformswitchingeventsinvariouscancertypeslessonsfrompancancerstudies
AT christianvonmering probingisoformswitchingeventsinvariouscancertypeslessonsfrompancancerstudies
AT christianvonmering probingisoformswitchingeventsinvariouscancertypeslessonsfrompancancerstudies
AT abdullahkahraman probingisoformswitchingeventsinvariouscancertypeslessonsfrompancancerstudies
AT abdullahkahraman probingisoformswitchingeventsinvariouscancertypeslessonsfrompancancerstudies
_version_ 1718406585853673472